145 related articles for article (PubMed ID: 229174)
1. Ocular infection with herpes simplex virus type 1: prevention of acute herpetic encephalitis by systemic administration of virus-specific antibody.
Davis WB; Taylor JA; Oakes JE
J Infect Dis; 1979 Oct; 140(4):534-40. PubMed ID: 229174
[TBL] [Abstract][Full Text] [Related]
2. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
Morrison LA; Knipe DM
Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
[TBL] [Abstract][Full Text] [Related]
3. Effect of immunization and immunosuppression on induced ocular shedding and recovery of herpes simplex virus in infected rabbits.
Green MT; Dunkel EC; Pavan-Langston D
Exp Eye Res; 1987 Sep; 45(3):375-83. PubMed ID: 2822456
[TBL] [Abstract][Full Text] [Related]
4. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
Ritchie MH; Oakes JE; Lausch RN
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of passive immunization on herpetic retinitis of newborn rabbits.
Friedlaender RP; Oh JO; Minasi P; Ohashi Y
Curr Eye Res; 1987 Jan; 6(1):161-6. PubMed ID: 3030640
[TBL] [Abstract][Full Text] [Related]
6. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.
Davido DJ; Tu EM; Wang H; Korom M; Gazquez Casals A; Reddy PJ; Mostafa HH; Combs B; Haenchen SD; Morrison LA
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950407
[TBL] [Abstract][Full Text] [Related]
7. Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system.
Shimeld C; Hill TJ; Blyth WA; Easty DL
J Gen Virol; 1990 Mar; 71 ( Pt 3)():681-7. PubMed ID: 2156001
[TBL] [Abstract][Full Text] [Related]
8. Different mechanisms of protection by monoclonal and polyclonal antibodies during the course of herpes simplex virus infection.
Eis-Hübinger AM; Mohr K; Schneweis KE
Intervirology; 1991; 32(6):351-60. PubMed ID: 1657825
[TBL] [Abstract][Full Text] [Related]
9. Interferon in the replication of herpes simplex virus in normal and pathological nerve cells.
de De La Peña NC; Bal E; Puricelli L; Diaz A; De Lustig ES
IARC Sci Publ (1971); 1978; (24 Pt 2):1055-66. PubMed ID: 221373
[TBL] [Abstract][Full Text] [Related]
10. Antibody-mediated recovery from subcutaneous herpes simplex virus type 2 infection.
Oakes JE; Rosemond-Hornbeak H
Infect Immun; 1978 Aug; 21(2):489-95. PubMed ID: 689732
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulation of experimental murine herpes simplex keratitis: I. UV-HSV protection.
Thompson P; Wells PA; Sandstrom IK; Opremcak EM; Millin JA; Daigle JA; Foster CS
Curr Eye Res; 1988 Nov; 7(11):1043-9. PubMed ID: 2854036
[TBL] [Abstract][Full Text] [Related]
12. Protection against herpetic ocular disease by immunotherapy with monoclonal antibodies to herpes simplex virus glycoproteins.
Metcalf JF; Chatterjee S; Koga J; Whitley RJ
Intervirology; 1988; 29(1):39-49. PubMed ID: 2838428
[TBL] [Abstract][Full Text] [Related]
13. Experimental ulcerative herpetic keratitis. I. Systemic immune responses and resistance to corneal infection.
Carter C; Easty DL
Br J Ophthalmol; 1981 Feb; 65(2):77-81. PubMed ID: 6257272
[TBL] [Abstract][Full Text] [Related]
14. CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8
Srivastava R; Khan AA; Chilukuri S; Syed SA; Tran TT; Furness J; Bahraoui E; BenMohamed L
J Virol; 2017 Jul; 91(14):. PubMed ID: 28468883
[TBL] [Abstract][Full Text] [Related]
15. Lyt-1+ T cells participate in recovery from ocular herpes simplex virus type 1 infection.
Oakes JE; Rector JT; Lausch RN
Invest Ophthalmol Vis Sci; 1984 Feb; 25(2):188-94. PubMed ID: 6321384
[TBL] [Abstract][Full Text] [Related]
16. Protective immunity against herpetic ocular disease in an outbred mouse model.
Metcalf JF; Whitley RJ
Curr Eye Res; 1987 Jan; 6(1):167-71. PubMed ID: 3030641
[TBL] [Abstract][Full Text] [Related]
17. Influence of experimental influenza infection of the eye on the course of herpetic keratitis in rabbits.
Zaitseva NS; Vinogradova VL; Krichevskaya GI
Acta Virol; 1978 Nov; 22(6):470-6. PubMed ID: 35945
[TBL] [Abstract][Full Text] [Related]
18. A gene capable of blocking apoptosis can substitute for the herpes simplex virus type 1 latency-associated transcript gene and restore wild-type reactivation levels.
Perng GC; Maguen B; Jin L; Mott KR; Osorio N; Slanina SM; Yukht A; Ghiasi H; Nesburn AB; Inman M; Henderson G; Jones C; Wechsler SL
J Virol; 2002 Feb; 76(3):1224-35. PubMed ID: 11773398
[TBL] [Abstract][Full Text] [Related]
19. Contrasting effects of immunosuppression on herpes simplex virus type I (HSV I) induced central nervous system (CNS) demyelination in mice.
Kastrukoff LF; Lau AS; Leung GY; Thomas EE
J Neurol Sci; 1993 Jul; 117(1-2):148-58. PubMed ID: 8410049
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulation of experimental murine herpes simplex keratitis: II. Glycoprotein D protection.
Foster CS; Sandstrom IK; Wells PA; Thompson P; Daigle J; Opremcak EM
Curr Eye Res; 1988 Nov; 7(11):1051-61. PubMed ID: 2854037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
